Top compounds associated with response to LHFPL3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA lapatinib UHNBreast pan-cancer AAC 0.38 0.2
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.046 0.2
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.041 0.2
mRNA MP470 GDSC1000 pan-cancer AAC 0.044 0.2
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA AS601245 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA YM201636 GDSC1000 pan-cancer AAC 0.04 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
Download CSV